{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T03:52:39Z","timestamp":1792036359338,"version":"4.4.0"},"reference-count":30,"publisher":"American Society of Hematology","issue":"4","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2007,8,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Very low-dose irradiation (2 \u00d7 2 Gy) is a new, effective, and safe local treatment for follicular lymphoma. To understand the biologic mechanisms of this extremely effective response, we compared by microarray the gene-expression profile of patients' biopsies taken before and after radiation. In all patients, a major and consistent induction of p53 target genes was seen. p53 targets involved in cell-cycle arrest and apoptosis showed the same mode of regulation, indicating that, in vivo, both are activated simultaneously. p53 up-regulation and p53-mediated proliferation arrest and apoptosis were substantiated using immunohistochemistry, with activation of both the intrinsic and the extrinsic apoptotic pathways. The other induced genes revealed a whole set of biologically meaningful genes related to macrophage activation and TH1 immune response. Immunohistochemical analysis suggested a specific activation or differentiation of resident macrophages by apoptotic cells. These biologic insights are important arguments to advocate the use of low-dose radiotherapy as an effective palliative treatment for follicular lymphoma. Moreover, this study is the first in vivo report of the radiation-induced p53 apoptotic response in patients and suggests that this apoptotic response is not immunologically silent.<\/jats:p>","DOI":"10.1182\/blood-2007-01-067579","type":"journal-article","created":{"date-parts":[[2007,5,4]],"date-time":"2007-05-04T21:14:36Z","timestamp":1178313276000},"page":"1116-1122","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":58,"title":["In vivo p53 response and immune reaction underlie highly effective low-dose radiotherapy in follicular lymphoma"],"prefix":"10.1182","volume":"110","author":[{"given":"Laurent","family":"Knoops","sequence":"first","affiliation":[{"name":"Department of Pathology, The Netherlands Cancer Institute, Amsterdam, the Netherlands;"},{"name":"Experimental Medicine and Hematology Units, Universit\u00e9 Catholique de Louvain, Brussels, Belgium;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rick","family":"Haas","sequence":"additional","affiliation":[{"name":"Departments ofRadiotherapy,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanne","family":"de Kemp","sequence":"additional","affiliation":[{"name":"Experimental Therapy and Diagnostic Oncology, and 6Hematology, The Netherlands Cancer Institute, Amsterdam, the Netherlands;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donn\u00e9","family":"Majoor","sequence":"additional","affiliation":[{"name":"Department of Pathology, The Netherlands Cancer Institute, Amsterdam, the Netherlands;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annegien","family":"Broeks","sequence":"additional","affiliation":[{"name":"Experimental Therapy and Diagnostic Oncology, and 6Hematology, The Netherlands Cancer Institute, Amsterdam, the Netherlands;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Eldering","sequence":"additional","affiliation":[{"name":"Department of Experimental Immunology, Academical Medical Centre, Amsterdam, the Netherlands;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan Paul","family":"de Boer","sequence":"additional","affiliation":[{"name":"Laboratory of Toxicology, Pathology and Genetics, National Institute of Public Health and the Environment, Bilthoven, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcel","family":"Verheij","sequence":"additional","affiliation":[{"name":"Departments ofRadiotherapy,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Conny","family":"van Ostrom","sequence":"additional","affiliation":[{"name":"Laboratory of Toxicology, Pathology and Genetics, National Institute of Public Health and the Environment, Bilthoven, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annemieke","family":"de Vries","sequence":"additional","affiliation":[{"name":"Laboratory of Toxicology, Pathology and Genetics, National Institute of Public Health and the Environment, Bilthoven, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"van't Veer","sequence":"additional","affiliation":[{"name":"Department of Pathology, The Netherlands Cancer Institute, Amsterdam, the Netherlands;"},{"name":"Experimental Therapy and Diagnostic Oncology, and 6Hematology, The Netherlands Cancer Institute, Amsterdam, the Netherlands;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daphne","family":"de Jong","sequence":"additional","affiliation":[{"name":"Department of Pathology, The Netherlands Cancer Institute, Amsterdam, the Netherlands;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"key":"2019111712102192900_B1","doi-asserted-by":"crossref","first-page":"6394","DOI":"10.1200\/JCO.2005.07.019","article-title":"Treatment strategies in follicular lymphomas: current status and future perspectives.","volume":"23","author":"Hiddemann","year":"2005","journal-title":"J Clin Oncol"},{"key":"2019111712102192900_B2","doi-asserted-by":"crossref","first-page":"2474","DOI":"10.1200\/JCO.2003.09.542","article-title":"High response rates and lasting remissions after low-dose involved field radiotherapy in indolent lymphomas.","volume":"21","author":"Haas","year":"2003","journal-title":"J Clin Oncol"},{"key":"2019111712102192900_B3","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/S0360-3016(01)01626-1","article-title":"A high and sustained response rate in refractory or relapsing low-grade lymphoma masses after low-dose radiation: analysis of predictive parameters of response to treatment.","volume":"51","author":"Girinsky","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2019111712102192900_B4","doi-asserted-by":"crossref","first-page":"5774","DOI":"10.1038\/sj.onc.1206677","article-title":"P53 and radiation responses.","volume":"22","author":"Fei","year":"2003","journal-title":"Oncogene"},{"key":"2019111712102192900_B5","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/j.ijrobp.2003.11.017","article-title":"In vivo imaging of radiation-induced apoptosis in follicular lymphoma patients.","volume":"59","author":"Haas","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2019111712102192900_B6","doi-asserted-by":"crossref","first-page":"14943","DOI":"10.1073\/pnas.96.26.14943","article-title":"Constitutive Bcl-2 expression throughout the hematopoietic compartment affects multiple lineages and enhances progenitor cell survival.","volume":"96","author":"Ogilvy","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2019111712102192900_B7","doi-asserted-by":"crossref","first-page":"3278","DOI":"10.1182\/blood-2004-08-3073","article-title":"Suppression of apoptosis by bcl-2 overexpression in lymphoid cells of transgenic zebrafish.","volume":"105","author":"Langenau","year":"2005","journal-title":"Blood"},{"key":"2019111712102192900_B8","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/j.ijrobp.2003.11.017","article-title":"In vivo imaging of radiation-induced apoptosis in follicular lymphoma patients.","volume":"59","author":"Haas","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2019111712102192900_B9","doi-asserted-by":"crossref","first-page":"e15","DOI":"10.1093\/nar\/30.4.e15","article-title":"Normalization for cDNA microarray data: a robust composite method addressing single and multiple slide systematic variation.","volume":"30","author":"Yang","year":"2002","journal-title":"Nucleic Acids Res"},{"key":"2019111712102192900_B10","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0092-8674(00)00015-5","article-title":"Functional discovery via a compendium of expression profiles.","volume":"102","author":"Hughes","year":"2000","journal-title":"Cell"},{"key":"2019111712102192900_B11","doi-asserted-by":"crossref","first-page":"e15","DOI":"10.1093\/nar\/30.4.e15","article-title":"Normalization for cDNA microarray data: a robust composite method addressing single and multiple slide systematic variation.","volume":"30","author":"Yang","year":"2002","journal-title":"Nucleic Acids Res"},{"key":"2019111712102192900_B12","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1093\/bioinformatics\/18.1.207","article-title":"Genesis: cluster analysis of microarray data.","volume":"18","author":"Sturn","year":"2002","journal-title":"Bioinformatics"},{"key":"2019111712102192900_B13","doi-asserted-by":"crossref","first-page":"5116","DOI":"10.1073\/pnas.091062498","article-title":"Significance analysis of microarrays applied to the ionizing radiation response.","volume":"98","author":"Tusher","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2019111712102192900_B14","doi-asserted-by":"crossref","first-page":"e153","DOI":"10.1093\/nar\/gng153","article-title":"Expression profiling via novel multiplex assay allows rapid assessment of gene regulation in defined signalling pathways.","volume":"31","author":"Eldering","year":"2003","journal-title":"Nucleic Acids Res"},{"key":"2019111712102192900_B15","first-page":"809","article-title":"Occurrence of chromosome 9 and p53 alterations in multifocal dysplasia and carcinoma in situ of human urinary bladder.","volume":"62","author":"Hartmann","year":"2002","journal-title":"Cancer Res"},{"key":"2019111712102192900_B16","first-page":"8108","article-title":"FGFR3 and TP53 gene mutations define two distinct pathways in urothelial cell carcinoma of the bladder.","volume":"63","author":"Bakkar","year":"2003","journal-title":"Cancer Res"},{"key":"2019111712102192900_B17","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1002\/humu.10081","article-title":"The IARC TP53 database: new online mutation analysis and recommendations to users.","volume":"19","author":"Olivier","year":"2002","journal-title":"Hum Mutat"},{"key":"2019111712102192900_B18","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1002\/humu.20284","article-title":"Predicting the transactivation activity of p53 missense mutants using a four-body potential score derived from Delaunay tessellations.","volume":"27","author":"Mathe","year":"2006","journal-title":"Hum Mutat"},{"key":"2019111712102192900_B19","doi-asserted-by":"crossref","first-page":"8424","DOI":"10.1073\/pnas.1431692100","article-title":"Understanding the function-structure and function-mutation relationships of p53 tumor suppressor protein by high-resolution missense mutation analysis.","volume":"100","author":"Kato","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2019111712102192900_B20","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S1535-6108(03)00244-7","article-title":"Puma is an essential mediator of p53-dependent and -independent apoptotic pathways.","volume":"4","author":"Jeffers","year":"2003","journal-title":"Cancer Cell"},{"key":"2019111712102192900_B21","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1126\/science.288.5468.1053","article-title":"Noxa, a BH3-only member of the Bcl-2 family and candidate mediator of p53-induced apoptosis.","volume":"288","author":"Oda","year":"2000","journal-title":"Science"},{"key":"2019111712102192900_B22","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/0092-8674(95)90412-3","article-title":"Tumor suppressor p53 is a direct transcriptional activator of the human bax gene.","volume":"80","author":"Miyashita","year":"1995","journal-title":"Cell"},{"key":"2019111712102192900_B23","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1084\/jem.192.3.359","article-title":"A hierarchical role for classical pathway complement proteins in the clearance of apoptotic cells in vivo.","volume":"192","author":"Taylor","year":"2000","journal-title":"J Exp Med"},{"key":"2019111712102192900_B24","doi-asserted-by":"crossref","first-page":"6366","DOI":"10.4049\/jimmunol.173.10.6366","article-title":"Apolipoprotein E modulates clearance of apoptotic bodies in vitro and in vivo, resulting in a systemic proinflammatory state in apolipoprotein E-deficient mice.","volume":"173","author":"Grainger","year":"2004","journal-title":"J Immunol"},{"key":"2019111712102192900_B25","doi-asserted-by":"crossref","first-page":"5774","DOI":"10.1038\/sj.onc.1206677","article-title":"P53 and radiation responses.","volume":"22","author":"Fei","year":"2003","journal-title":"Oncogene"},{"key":"2019111712102192900_B26","doi-asserted-by":"crossref","first-page":"6368","DOI":"10.1158\/0008-5472.CAN-04-1883","article-title":"Human in vivo radiation-induced biomarkers: gene expression changes in radiotherapy patients.","volume":"64","author":"Amundson","year":"2004","journal-title":"Cancer Res"},{"key":"2019111712102192900_B27","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1182\/blood-2003-09-3236","article-title":"Fludarabine treatment of patients with chronic lymphocytic leukemia induces a p53-dependent gene expression response.","volume":"104","author":"Rosenwald","year":"2004","journal-title":"Blood"},{"key":"2019111712102192900_B28","doi-asserted-by":"crossref","first-page":"6358","DOI":"10.1200\/JCO.2005.26.856","article-title":"Molecular pathogenesis of follicular lymphoma: a cross talk of genetic and immunologic factors.","volume":"23","author":"de Jong","year":"2005","journal-title":"J Clin Oncol"},{"key":"2019111712102192900_B29","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/j.ijrobp.2003.11.017","article-title":"In vivo imaging of radiation-induced apoptosis in follicular lymphoma patients.","volume":"59","author":"Haas","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2019111712102192900_B30","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1056\/NEJMe048291","article-title":"Radioimmunotherapy: hot new treatment for lymphoma.","volume":"352","author":"Connors","year":"2005","journal-title":"N Engl J Med"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/110\/4\/1116\/1479231\/zh801607001116.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/110\/4\/1116\/1479231\/zh801607001116.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,17]],"date-time":"2019-11-17T12:10:44Z","timestamp":1573992644000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/110\/4\/1116\/23117\/In-vivo-p53-response-and-immune-reaction-underlie"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,8,15]]},"references-count":30,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2007,8,15]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2007-01-067579","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,8,15]]}}}